Efficacy of Pabolizumab combined with chemotherapy in the treatment of advanced non-small cell lung cancer and its effect on tumor markers and gastrointestinal response

JIANG Shu; LI Chenghui; XIE Lili; WANG Aijuan

doi:10.3969/j.issn.1674-4136.2023.02.010

Home>Articles>Efficacy of Pabolizumab combined with chemotherapy in the treatment of advanced non-small cell lung cancer and its effect on tumor markers and gastrointestinal response

DOI: 10.3969/j.issn.1674-4136.2023.02.010

Efficacy of Pabolizumab combined with chemotherapy in the treatment of advanced non-small cell lung cancer and its effect on tumor markers and gastrointestinal response

JIANG Shu

LI Chenghui

XIE Lili

WANG Aijuan

Machine-generated Keywords：

Publication Date：2023-04-20

Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)

Pages：4( 158-161 )

Chinese Journal of Surgical Oncology

ISTIC

ISSN：1674-4136

Year, Vol.(Issue)：2023,15(2)